Open-Label Expanded Access Treatment With Pegunigalsidase Alfa for Fabry Disease Patients
Clinical trial NCT04552691 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04552691
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.